loqi / journal
The reading behind LOQI.
After MDMA changed what I thought was possible, I read something like ninety books. I wanted the research, but also the accounts that made it feel human. These are books I’d put into a friend’s hands, with a few words about where each one might take you.
Read the research
Primary studies referenced in the writing. Findings apply to the people, conditions, and forms of support studied; a promising result is the beginning of further questions.
MDMA-assisted therapy for PTSD
Mitchell et al. · Nature Medicine · 2023. A randomized phase 3 trial in 104 adults; both groups received therapy.
Psilocybin for treatment-resistant depression
Goodwin et al. · New England Journal of Medicine · 2022. A randomized phase 2 trial in 233 adults with psychological support and a three-week primary endpoint.
5-MeO-DMT and treatment-resistant depression
Cubała et al. · JAMA Psychiatry · 2026. A randomized trial of synthetic GH001 in 81 adults, with a seven-day controlled period.
Support & harm reduction
DanceSafe
Drug-checking education, reagent kits, and fentanyl test strips. Start with current instructions and the limits of each tool: reagents cannot establish purity, and an expected result does not mean a substance is safe.
Fireside Project
Psychedelic peer support for people navigating experiences and their aftermath. Visit the organization for current availability and contact details.
Zendo Project
Peer-support education and care at participating events, grounded in a compassionate approach to difficult experiences.
MAPS Integration Station
Resources from MAPS, a research and advocacy nonprofit, with integration frameworks and reflective exercises for considering how an experience relates to the rest of your life.
Back to the shelf index
Make sense of what’s next.
If you’re considering an experience or trying to understand one you’ve had, I offer preparation and integration support. We begin with what matters to you, what has helped so far, and what you want to explore next.